TriHealth is notifying individuals whose information was involved in a recent third-party data security incident. Click here for more information. Click here for additional information on the recent Datavant Breach.
| Study Title | IRB/Hatton# |
|---|---|
| Impact of defecation posture on ease of first bowel movement following posterior repair | 23-087 |
| Impact of defecation posture on ease of bowel movements in patients with a rectocele | 23-090 |
| Utilizing a care pathway to improve attrition rates in overactive bladder patients (QI) | 23-091 |
| Effect of postoperative educational video for catheter care (QI) | TBD |
| Use of a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in patients undergoing retropubic mid-urethral sling surgery | 22-102 |
| Severity of symptoms at presentation in black women with overactive bladder | 23-016 |
| Postoperative Antibiotics Following Sacral Neuromodulation Implant Surgery | 23-038 |
| Pelvic floor disorders and Ehler’s Danlos/Connective tissue disease | 23-060 |
| Effect of peri-operative bundle on incidence of symptomatic postoperative UTI in a urogynecology practice (QI) | 23-068 |
| Silver-coated catheter versus standard catheter for UTI prevention in a short-term transurethral indwelling catheter population after pelvic reconstructive surgery | 22-004 |
| Evaluation of preoperative counseling video on anxiety in patients undergoing prolapse surgery | 22-094 |
| Motivations of long‐term pessary users: A qualitative study | 22-112 |
| Comparing postoperative pain after LigaSureTM vessel sealing device versus conventional suturing methods for vaginal hysterectomy and pelvic reconstructive surgery | 21-094 |
| Is same day discharge (SDD) following total vaginal hysterectomy (TVH) and pelvic reconstruction feasible and safe? | 21-101 |
| Comparison of Urine pH Levels and Pain Scores in Patients with an Active Interstitial Cystitis Flare | 21-110 |
| Effect of Postoperative Educational Video on Caregiver Preparedness Following Urogynecologic Surgery | 22-067 |
| Composur, A Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Patients with Overactive Bladder | 21-073 |